Contribute Try STAT+ Today

When it comes to prescription drug prices, what goes up often continues to go up – and 2021 is no exception.

Each January, the pharmaceutical industry is known for raising prices. And this month, the median wholesale price increased 4.8% for 645 brand-name medicines in the U.S., according to a new analysis by 46Brooklyn, a market research firm.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • Ed,

    Nice job highlighting the disconnect between list prices and actual discounted prices. The role of list prices for the computation of coinsurance and deductibles is grossly unfair, especially when net prices for brand-name drugs have declined for the past three years.

    Alas, STAT (like every other new outlet) fails to report on list price changes for the other 85%+ of US healthcare costs, where net prices never decline and *every* aspect of healthcare (hospital costs, physician salaries, etc.) is much more expensive than the US. 

Comments are closed.